An economic topology of the reactive economy — what the current system extracts per million lives, beside the architecture of what it cannot yet see. Every figure sourced to federal administrative data or peer-reviewed research.
Every operator inside healthcare today is a node in this flow. What follows is what the reactive economy already costs per million commercially insured lives — across six cost channels and the substrate that now measures the 93% upstream. Every dollar anchored to federal administrative data or peer-reviewed research. No vendor surveys, no consulting estimates, no industry attestations.
A payer covers every member — but only about 7% are ever measured for behavioral risk before a claim arrives. The other 93% are unmeasured, unmanaged, and unpriced. That 93% is not a single statistic. It compounds from three documented gaps in the screening funnel: most members are never screened at all (penetration), roughly a quarter of those screened are misclassified (sensitivity), and about two-thirds of positive screens never convert to care (routing). Trace it through a million members: roughly 750,000 are never screened at all. Of the ~250,000 who are, about a quarter are misclassified by single-test screening. And of those correctly flagged, roughly two-thirds never complete the path to care. Fewer than 70,000 — about 7% — make it through all three gaps to measured, routed care. The rest are the 93%. The cost below is what the reactive economy spends absorbing behavioral risk — 93% of which is never measured before it becomes a claim.
This is macroeconomic infrastructure, not a clinical category. Stated plainly: the healthcare system is downstream accounting for upstream behavioral volatility it cannot currently see. The economy is reactive for a single reason — the risk is unmeasured, so it goes unmanaged, so the system can only respond downstream, after the claim, the crisis, the loss. Measurement is the only thing that breaks the cascade.
A downstream collision architecture.
An upstream coordinate system for the 93%.
The reactive economy spends $2.36 billion per million lives — and 93% of the people generating that cost are never measured before the bill arrives.
Every figure above is federally sourced and auditable. What follows shows where the money settles — and the instrument that measures the 93% before they become a claim.
The $2.36B above is anchored entirely in federal and peer-reviewed sources. The decomposition that follows allocates that aggregate across operator classes — by where the spend settles, not where it originates.
The figures above are not only a cost. They are a ceiling. The operators in the flow — clinics, care-management services, digital health platforms, networks — are structurally limited to the share of the population that presents clinically. They are competing for the same thin slice, catching the raindrops that fall. Capacity-capped. Labor-constrained. Multiple-compressed. This is capital degradation economics — the slow compression of enterprise value across a portfolio operating without upstream visibility into the risk it already carries. These pressures do not arrive separately. Labor inflation, acuity escalation, unmanaged comorbidity, emergency-department collision, boarding drag, reimbursement pressure — they compound, and behavioral risk sits upstream of nearly all of them, invisible. A portfolio absorbing that load is suffocating on downstream volatility it cannot see.
An asset capped at the 7% who present clinically carries the multiple of a capacity-constrained service. An asset positioned on the operating system that measures the 100% carries the multiple of infrastructure. The substrate does not pick one participant to win — it is non-rivalrous. Every credentialed institution in the flow re-rates against the expanded population at once. A ceiling this low does not just compress individual assets. It suppresses the capital and innovation that would otherwise compound on top of behavioral risk — because no one builds durable enterprise value, and no one deploys patient capital, on a foundation that can only see 7% of the population.
Everything above describes a system that absorbs deterioration instead of preventing it. Value-based care is the entire industry's attempt to reverse that — to pay for outcomes instead of volume, to optimize for value instead of crisis. It is a federal mandate and a multi-hundred-billion-dollar migration. And it rests on a floor with a hole in it.
You cannot manage value on a population you cannot measure.
Every value-based contract takes on risk for an entire population — yet the behavioral risk driving the comorbidity multiplier and the downstream tax is invisible across 93% of that population. The risk most responsible for degrading the value these contracts are written to deliver is the risk no one can see. Value-based care has been trying to re-point the system without the instrument that makes behavioral risk legible.
That instrument is the substrate described on this page. Not a program inside value-based care — the measurement layer underneath it. When the 93% becomes visible, prevention becomes economically legible for the first time, and the system can finally optimize for the outcome it was always supposed to: fewer people deteriorating, before the bill — and before the loss.
The Oxygen Plan Corporation is the governance entity to which participants license. Institutions engage the substrate through structured Vault Access — oriented to the depth of the institution's role in the standard.
The category forms once. The institutions that engage while the standard is being established hold structural positions; those that arrive after license the standard rather than help govern it.
The same evidentiary standard the Pre-Diagnostic Index™ holds. No vendor research. No consulting estimates. No industry attestations. If a source cannot be linked to a federal administrative dataset or a peer-reviewed journal, it does not appear above.
A published reference format for the Behavioral Risk Economy decomposition — for use in clinical, regulatory, actuarial, and contractual contexts.